Residual Inflammation May Increase Post-Procedure Risk
Patients who have had heart procedures should talk to their doctor about inflammation, which can affect heart risks.
Updated on Oct. 29, 2026 in Heart Disease
Live Poll
Should doctors test for inflammation levels to better manage heart health after a surgery?
A recent study of patients who underwent percutaneous coronary intervention shows that residual inflammation may increase the risk of major cardiovascular events. This finding highlights a potential concern for New York City patients even when traditional risk factors like cholesterol and blood pressure are well-controlled.
Why it matters
Even when patients hit clinical targets for cholesterol and blood pressure, this underlying inflammation appears to influence long-term outcomes. Understanding this risk is a critical step in managing heart health following common heart procedures.
In a retrospective analysis of 3,887 patients who underwent percutaneous coronary intervention, researchers found that high-sensitivity C-reactive protein levels of 2 mg/L or higher were associated with a 58% higher risk for major cardiovascular events. These results are preliminary and based on single-timepoint measurements.
The players
Heart
A peer-reviewed medical journal that publishes research on cardiovascular disease and clinical practice.
The details
The study tracked patients using high-sensitivity C-reactive protein (hsCRP) as a marker of systemic inflammation. When this marker is elevated, it suggests that even if standard markers like LDL cholesterol, blood pressure, and A1c are within recommended ranges, an inflammatory process may still persist. Researchers observed that this specific profile correlates with higher mortality and adverse heart events, though the mechanism behind this specific disparity requires further investigation.
Timeline
January 2012 to December 2023: Patients underwent percutaneous coronary intervention.
October 21, 2026: Study results were published in the journal Heart.
Health Landscape
This study shifts the focus of post-procedure care beyond the traditional lipid-lowering targets that have dominated cardiology for decades. It aligns with broader research efforts investigating how systemic inflammation functions as a distinct, actionable pathway in preventing cardiovascular mortality.
If you have recently undergone heart procedures, it is worth discussing with your cardiologist whether checking inflammatory markers like hsCRP is appropriate for your long-term follow-up plan. This is especially relevant if you feel you have your blood pressure and cholesterol numbers under control but are still concerned about your heart health.
The takeaway
Residual inflammation appears to be a significant, independent risk factor for heart patients that persists even when other targets are met. Ask your physician if screening for inflammatory markers is a useful component of your current cardiovascular monitoring strategy.
Further reading
For more information on managing heart health after procedures, visit Heart Disease.
Source note: This article includes information reported by Medscape.
Live Poll
Should doctors test for inflammation levels to better manage heart health after a surgery?
